Consider Comorbid Health Conditions Patients with weight-related comorbidities such as type 2 diabetes, sleep apnea, or heart disease may be advised to continue GLP-1 therapy to manage these conditions in conjunction with weight loss
However, clinicians should recognize that any use of GLP-1 agonists in Crohn's disease patients remains off-label and requires careful consideration of the established evidence base for IBD management
As their use grows their side effects make headlines
Medication amplifies your effort
Related Reading How to Prevent Hair Loss on Ozempic Semaglutide Protein Intake How to Fix Ozempic Face Naturally Wegovy Injection Site Pain Does Mounjaro Make You Sleepy Does Semaglutide Give You Energy Wegovy Insomnia How to Combat Wegovy Fatigue Tirzepatide Muscle Aches How to Get Wegovy Out of Your System Faster Does Semaglutide Affect Hormones Download our GLP-1 app to Turn Your Weight Loss Journey into Your Favorite Game When you start Ozempic, Wegovy, or Mounjaro, the results can come fast
Lets break down why this approach is a total game-changer